Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.
The Scientist
Most Recent
How plants pass defenses to offspring through a complex molecular network
Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of d
Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.
Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.
Major pharmaceutical companies have agreed to a handful of recommendations aimed at increasing the transparency of clinical trials they fund.
The diversity of microbes in the great outdoors may protect against inflammatory disorders.
Techniques for simpler, cheaper, and better antibody purification
A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.
A combination of antibiotics and the body’s own defensive metabolites clears bacterial infections faster than antibiotics alone.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
